Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Systemair Annual and Sustainability Report 2020/21 is now available online

Press Release, 3 August 2021 Systemair AB (NASDAQ OMX Stockholm: SYSR) announced today that the company's Annual and Sustainability Report for 2020/21 is published, see the attached file. The Annual and Sustainability Report is also published on the company's website group.systemair.com, in both Swedish and English versions. A printed Annual overview will be distributed shortly to those who have expressed an interest. A printed Annual overview can also be ordered on the website. For further information, please contact: Roland Kasper, CEO + 46 (0)73 094 40 13 Anders Ulff, CFO

Vestas wins 58 MW order for wind project in Australia

News release from Vestas Asia PacificSingapore, 3 August 2021 In partnership with Global Power Generation, a subsidiary of the multinational power company Naturgy Group, Vestas has secured a 58 MW deal for Crookwell 3 Wind Farm in New South Wales, Australia. The project will feature 16 V126-3.45 MW wind turbines in 3.6 MW operating mode which Vestas will supply and install. Upon completion, Vestas will also deliver a 15-year Active Output Management 5000 (AOM 5000) service agreement. This agreement will optimise energy production while also providing long-term business case

BioStock: Saniona's CMO on the FDA Orphan Drug Designation for Tesomet in HO

Last week, Saniona announced that the U.S. Food and Drug Administration has granted orphan drug designation to Tesomet for the treatment of hypothalamic obesity (HO), making Saniona the first company to achieve this milestone. BioStock reached out to Rudolf Baumgartner, MD, Chief Medical Officer and Head of Clinical Development at Saniona, to learn more about the significance of the FDA’s decision, as well as the plans to initiate phase IIb studies in the second half of 2021 for both HO and Prader-Willi syndrome (PWS) – an indication the company obtained orphan drug status for from the FDA

Study shows that myFC's fuel cell technology can solve the interior heating of electric cars

Interior heating that can withstand a Nordic climate is a challenge for all manufacturers of electric vehicles. Excessive energy consumption when using an electric heating element risks adversely affecting the range of a conventional battery-powered vehicle.But what about a fuel cell powered vehicle?Is it possible to use the waste heat that the fuel cell produces to heat a passenger compartment? And how energy efficient is it compared to conventional technology? Could there be other effects? With these issues as a starting point, myFC together with Inzile, who manufactures light

Nordnet: Monthly statistics July

In July, 4,819,900 trades were made in listed financial instruments among Nordnet’s customers in Sweden, Norway, Denmark and Finland. That corresponds to 219,100 trades per day. The number of customers at the end of July was 1,494,400 which is 19,100 more than previous month. Net savings for July was SEK 6.4 billion and the total net savings during 2021 is SEK 55.8 billion. The savings capital was SEK 727 billion and lending amounted to SEK 23.4 billion at the end of July.[][][] July June Change  July Change  2021¹ 2021

Musti Group will publish its Interim Report for October 2020 – June 2021 on Tuesday, 10 August 2021

Musti Group plc                        Press Release 3 August 2021 at 9.30 a.m. Musti Group will publish its Interim Report for October 2020 – June 2021 on Tuesday, 10 August 2021 Musti Group will publish its Interim Report for October 2020 – June 2021 on Tuesday, 10 August 2021 at 8:30 a.m. EEST. The report will be available at https://www.mustigroup.com/investors/reports-and-presentations/ after publication. A webcast and international telephone conference for analysts and media will be arranged on the publishing day at 2:00 p.m. EEST. The event will be held in English. The

Spago Nanomedical appoints Paul Hargreaves as Chief Development Officer

Spago Nanomedical AB (publ) announced today that Paul Hargreaves has been appointed Chief Development Officer (CDO), starting September 13. He will join the management team and have a key role in the clinical development of the company´s project portfolio.The appointment of Paul Hargreaves as CDO marks an important step for Spago Nanomedical as the company continues to make progress with its unique project portfolio, with the Tumorad[®] candidate drug SN201 rapidly advancing towards clinical trials. This is an opportunity to provide potential treatment for advanced cancers of different

Adapteo Q2: Continued growth in 2021

Adapteo Plc Regulatory press release 03 August 2021 at 8:00 a.m.CEST April-June 2021 · Rental sales[1] amounted to EUR 41.1 (32.8 in Q2 2020) million. In constant currencies, rental sales increased by 21.4%. · Net sales[1] amounted to EUR 70.7 (57.8) million. In constant currencies, net sales increased by 18.9%. · Comparable EBITDA[1] was EUR 26.7 (21.8) million. Comparable EBITDA margin was 37.8% (37.7%). · Operating cash flow before new building capex[1] was EUR 16.9 (27.9) million.  [1] 2021 figures include the consolidation of the Dutch Cabin Group and Stord

Summons to the Extraordinary General Meeting of shareholders in Castellum AB (publ)

The shareholders of Castellum AB (publ), Reg. No. 556475-5550, are hereby summoned to the Extraordinary General Meeting to be held on Friday, August 27, 2021.In order to minimize any risk of spreading of the corona virus, the Board of Directors has decided that the Extraordinary General Meeting is to be held only through advance voting (postal voting) in accordance with temporary legislation. This means that the Extraordinary General Meeting will be conducted without the physical presence of shareholders, representatives or external parties and that shareholders will only be able to

NENT Group announces first Polish Viaplay Originals

· ‘Polish Murderesses’, ‘Black Dog’ and ‘Freedom of the Swallow’ now entering development · Katarzyna Bonda, Poland’s most popular crime writer, and other star names attached · Viaplay available in Poland from 3 August Nordic Entertainment Group (NENT Group) has launched ‘Polish Murderesses’, ‘Black Dog’ and ‘Freedom of the Swallow’ as its first scripted Viaplay Originals in Poland. The shows explore an eye-opening range of compelling and often groundbreaking themes, and are in development with some of Poland’s most well-known and exciting creative talents. Polish, Nordic and

Moberg Pharma’s Interim report for January – June 2021 to be published on August 10 - Invitation to teleconference

STOCKHOLM, August 3[rd], 2021 – On August 10[th], 2021, at 08:00 am (CET), Moberg Pharma AB (OMX: MOB) will present its Interim report for January – June 2021. Investors, analysts and journalists are hereby invited to participate in a teleconference at 3:00 pm (CET) on the same date.The teleconference will be hosted by Moberg Pharmas’s CEO Anna Ljung and VP Finance Mark Beveridge. The presentation will be held in English. Date:             August 10[th], 2021Time:             3:00 pm (CET) To participate in the conference, please dial in on any number below before the start of the

Holding(s) in Company

TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00B635TG28 Issuer Name ENQUEST PLC UK or Non-UK Issuer UK  2. Reason for Notification An acquisition or disposal of financial instruments  3. Details of person subject to the notification obligation Name Helikon Investments Limited City of registered office (if applicable) London Country of registered office (if applicable) United Kingdom 4. Details of the shareholder Name City of registered office Country of registered officeHelikon

Detection Technology Plc half-yearly report January–June 2021

Detection Technology Plc company announcement 3 August 2021 at 09:00 (EEST) DETECTION TECHNOLOGY PLC HALF-YEARLY REPORT JANUARY–JUNE 2021 Detection Technology Q2 2021: Return to growth, improved outlook April-June 2021 highlights · Net sales increased by 11.5% to EUR 23.5 million (21.1) · Net sales of Industrial Solutions Business Unit (IBU) decreased by -10.4% to EUR 3.1 million (3.4) · Net sales of Medical Business Unit (MBU) increased by 37.4% to EUR 13.6 million (9.9) · Net sales of Security Business Unit (SBU) decreased by -11.7% to EUR 6.9 million (7.8) ·

FlexQubes report for the second quarter 2021

SECOND QUARTER 2021 · Order intake increased by 54.4 percent to SEK 32.4 million (21.0). Adjusted for foreign exchange rate effects between the comparison periods, orders received increased by 75.1 percent. · Net sales increased by 47.3 percent to SEK 26.5 million (18.0). Adjusted for foreign exchange rate effects between the comparison periods, net sales increased by 67.1 percent. · Operating profit before depreciation (EBITDA) amounted to SEK -1.6 million (-1.8) and operating profit before financial items (EBIT) amounted to SEK -2.7 million (-3.0). · Profit before tax

Limited liability companies and co-operatives must submit financial statements to the Finnish Trade Register; even active businesses may risk deregistration

The Finnish Patent and Registration Office (PRH) will this week send reminder letters to about 1,900 limited liability companies and co-operatives that have not submitted their financial statements for registration within one year from the end of the financial period. The PRH can deregister even an active business if it does not file the financial statements by the date given on the letter.Deregistration means that the business is out of action. All limited liability companies and co-operatives must file their financial statements with the Trade Register for each financial period, even

Loyal Solutions announces global agreement with Visa

Loyal Solutions (NASDAQ: LOYAL (ISIN DK0061535507) can proudly announce a new global SaaS loyalty platform agreement with Visa Inc., the world leader in digital payments. Our SaaS technology and our  platform LoyalTfacts®, will power a new global SaaS loyalty platform for Visa.The new cooperation on the Visa SaaS loyalty platform, builds on the existing five year relationship between the organizations.Visa will be using LoyalTfacts® to support a variety of consumer engagement opportunities across the globe. It is to early to quantify the impact of the agreement on the future financial

Nanoform and Boehringer Ingelheim execute master services agreement

Press release Nanoform Finland Plc August 3, 2021 08:10 a.m. Finnish time / 07:10 a.m. Swedish time Nanoform and Boehringer Ingelheim execute master services agreement Helsinki, Finland – Nanoform, an innovative nanoparticle medicine enabling company, announces that Proof of Concept studies may now be performed for Boehringer Ingelheim to assess the added value Nanoform’s award-winning CESS[®] technology can deliver to its drug development projects. The two parties have executed a master services agreement (MSA) to initiate projects in the pre-clinical early development

EU approves funding for Twence’s carbon capture project

The European Commission has found a €14.3 million Dutch investment aid to Twence Holding BV to build a carbon capture and use facility to be in line with EU State aid rules.The project will enable the removal of CO2 from flue gases at the Twence’s waste-to-energy installation facility located at Hengelo, in the Netherlands. The captured liquid CO2 will be used primarily by greenhouses in the horticultural sector, where it is to be used to enhance crop growth. The investment project relates to the capturing process and equipment of the liquefied CO2.  “We are pleased to see the proposed

Norway Royal Salmon ASA (NRS): Acceptances received under mandatory offer to acquire all shares in Norway Royal Salmon ASA

Reference is made to the mandatory offer (the "Offer") from NTS ASA (the "Offeror") to acquire all shares in Norway Royal Salmon ASA ("NRS" or the "Company") pursuant to an offer document dated 16. July 2021, at an offer price of NOK 209 per share and with an offer period from 19 July 2021 to 16 August 2021 at 16:30 CEST (subject to extension) (the "Offer"). On 2 August 2021, the Offeror received acceptance under the Offer for 718 shares. The Offeror has during the Offer Period received acceptances for in total 2,536 shares in NRS. In addition, NTS has acquired 601,871 shares in NRS over

Registration of share capital reduction

Reference is made to the resolution by the annual general meeting on 2 June 2021 where a resolution was passed to reduce the Company's share capital by cancellation of treasury shares. The share capital reduction has now been registered with the Norwegian Register of Business Enterprises, and the new registered share capital of the Company is NOK 2 494 994,54 and the total share count is 124 749 727, each having a par value of NOK 0,02.   Petter Lade, CFO Phone: +47 91143878 E-mail: petterl@otellocorp.com

Brighter receives clarification from the United Arab Emirates Ministry of Health and Prevention regarding data storage and processing in Actiste® Diabetes Management Solution

Brighter AB (Publ) (“Brighter” or “the Company”) announced today that the United Arab Emirates (UAE) Ministry of Health and Prevention (MoHAP) has notified the Company of a preliminary assessment clarifying certain matters relating to data storage and processing in Actiste® Diabetes Management Solution. On the basis of a technical evaluation, MoHAP considers that Brighter’s Actiste® device falls under the “simple device” categorization (pursuant to Ministerial Decision No. 51/2021 (the "Decision") providing for exemptions under UAE Federal Law No.2 of 2019 (“Health Data Law”)). Provided

Cederquist advisor to the Board of Directors of Kungsleden in connection with Castellum’s public tender offer

On 2 August 2021, Castellum AB announced a public tender offer to the shareholders in Kungsleden AB. The consideration in the offer consists of a combination of shares in Castellum and cash. The public offer values the shares in Kungsleden to approximately SEK 26.9 billion in total. Cederquist is legal advisor to the Board of Directors of Kungsleden in connection with the public offer. Both Kungsleden and Castellum are listed at Nasdaq Stockholm, Large Cap. Cederquist's team includes Tone Myhre-Jensen, Anna Green Jensen, Wilhelm Lüning and Julia Amanda Nilsson (ECM), Per Henriksson (

#21-256 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

VO2 executes reverse take over with Nasdaq First North listed Curando Nordic

It was today announced that VO2 executes a reverse take over with Curando Nordic, listed on Nasdaq First North. After Curando Nordic’s extra shareholders’ meeting, that likely will be held at the end of July, VO2 foresees that its share will be listed on Nasdaq First North.Friday June 11, 2021 It was today announced that VO2 executes a reverse take over with Curando Nordic, listed on Nasdaq First North. After Curando Nordic’s extra shareholders’ meeting, that likely will be held at the end of July, VO2 foresees that its share will be listed on Nasdaq First North. Douglas Roos,

There are no items matching the current filter
There are no more items matching the current filter
Back to top